MET and non-small cell lung carcinoma: For example, studies demonstrated that suppression of miR-27a (Acunzo et al., 2013), miR-27b (Zhou et al., 2017), miR-34a (Hong et al., 2015), and miR-34b (Wang et al., 2013) impairs NSCLC progression by regulating c-Met.